John is Chief Executive Officer and Co-Founder of Artrya, an applied artificial intelligence healthcare company that is developing solutions for clinicians to accurately diagnose patients at risk of heart disease and guide them in delivering more effective treatments. At Artrya, we are changing the way heart disease is diagnosed by using artificial intelligence to deliver faster and more accurate diagnosis of Coronary Artery Disease, and ultimately save lives. Artrya is Perth-based with a team comprising of world-leading researchers in heart disease & developers in Artificial Intelligence.
Previously, John was the Global Industry Leader at IBM where he advised CEOs and Boards of some of the world’s largest corporations on commercialisation, strategy, digital transformation and enabling growth in markets such as Asia, US and Europe. He was also a member of IBM’s Global Industry Academy, recognised as top Industry Executives in IBM.